COR Cencora Inc.
- Stocks
- Healthcare
- NYSE: COR
Price (delayed)
$289.15
Market cap
$56.06B
P/E Ratio
29.48
Dividend/share
$2.16
EPS
$9.81
Enterprise value
$62.07B
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in
Highlights
The equity has soared by 114% YoY and by 96% from the previous quarter
COR's gross profit is up by 14% year-on-year and by 4.7% since the previous quarter
COR's P/E is 29% above its 5-year quarterly average of 22.8 but 4.6% below its last 4 quarters average of 30.9
The company's quick ratio rose by 4.2% QoQ but it fell by 3.8% YoY
The company's debt has surged by 74% YoY and by 4.9% QoQ
Key stats
What are the main financial stats of COR
Market
Valuations
Earnings
Shares outstanding
193.88M
Market cap
$56.06B
Enterprise value
$62.07B
Price to earnings (P/E)
29.48
Price to book (P/B)
28.3
Price to sales (P/S)
0.18
EV/EBIT
22.21
EV/EBITDA
18.96
EV/Sales
0.2
Revenue
$316.65B
Gross profit
$11.02B
Operating income
$2.73B
Net income
$1.9B
EBIT
$2.79B
EBITDA
$3.27B
Free cash flow
$1.14B
Per share
Balance sheet
Liquidity
EPS
$9.81
EPS diluted
$9.74
Free cash flow per share
$5.89
Book value per share
$10.22
Revenue per share
$1,633.74
TBVPS
$287.39
Total assets
$73.96B
Total liabilities
$71.75B
Debt
$8.24B
Equity
$1.98B
Working capital
-$5.14B
Debt to equity
4.16
Current ratio
0.9
Quick ratio
0.5
Net debt/EBITDA
1.84
Margins
Efficiency
Dividend
EBITDA margin
1%
Gross margin
3.5%
Net margin
0.6%
Operating margin
0.9%
Return on assets
2.7%
Return on equity
196.3%
Return on invested capital
53.4%
Return on capital employed
14%
Return on sales
0.9%
Dividend yield
0.75%
DPS
$2.16
Payout ratio
22%
COR stock price
How has the Cencora stock price performed over time
Intraday
-0.53%
1 week
-1.09%
1 month
-2.05%
1 year
21.61%
YTD
28.69%
QTD
-3.57%
Financial performance
How have Cencora's revenue and profit performed over time
Revenue
$316.65B
Gross profit
$11.02B
Operating income
$2.73B
Net income
$1.9B
Gross margin
3.5%
Net margin
0.6%
The company's net margin rose by 20% QoQ but it fell by 14% YoY
COR's gross profit is up by 14% year-on-year and by 4.7% since the previous quarter
Cencora's operating margin has increased by 13% from the previous quarter
Cencora's revenue has increased by 12% YoY and by 2.1% QoQ
Price vs fundamentals
How does COR's price correlate with its fundamentals
Growth
What is Cencora's growth rate over time
Valuation
What is Cencora stock price valuation
P/E
29.48
P/B
28.3
P/S
0.18
EV/EBIT
22.21
EV/EBITDA
18.96
EV/Sales
0.2
COR's P/E is 29% above its 5-year quarterly average of 22.8 but 4.6% below its last 4 quarters average of 30.9
COR's EPS is up by 13% since the previous quarter and by 5% year-on-year
The equity has soared by 114% YoY and by 96% from the previous quarter
The price to book (P/B) is 67% lower than the last 4 quarters average of 85.7
The P/S is 80% above the 5-year quarterly average of 0.1 but 10% below the last 4 quarters average of 0.2
Cencora's revenue has increased by 12% YoY and by 2.1% QoQ
Efficiency
How efficient is Cencora business performance
Cencora's ROIC has plunged by 53% YoY and by 20% from the previous quarter
The ROE has declined by 19% since the previous quarter and by 9% year-on-year
COR's return on sales is up by 13% since the previous quarter
The company's return on assets rose by 8% QoQ but it fell by 7% YoY
Dividends
What is COR's dividend history
DPS
$2.16
Dividend yield
0.75%
Payout ratio
22%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Cencora financials performed over time
COR's total assets is 3.1% greater than its total liabilities
COR's total assets is up by 11% year-on-year and by 3.9% since the previous quarter
Cencora's total liabilities has increased by 9% YoY and by 2.5% from the previous quarter
The equity has soared by 114% YoY and by 96% from the previous quarter
The company's debt has surged by 74% YoY and by 4.9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.